Go or no go? A quiet month ahead for US approval verdicts

Go or no go? A quiet month ahead for US approval verdicts

Submitted by admin on August 28, 2020 - 10:29am
Source: 
EP Vantage
News Tags: 
FDA
Bristol-Myers Squibb
CC-486
AML
Mallinckrodt
terlipressin
Mesoblast
Ryoncil
Headline: 
Go or no go? A quiet month ahead for US approval verdicts
snippet: 

A decision is due on Bristol’s new leukemia project, while Mallinckrodt and Mesoblast await their fates after mixed panel meetings.

Do Not Allow Advertisers to Use My Personal information